Dichlorphenamide Tablet
Product Images NDC 16571-242

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dichlorphenamide (NDC 16571-242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclorophenamide-label.jpg (Diclorophenamide Label)

This text provides information about Dichlorphenamide tablets manufactured in India by Rising Pharma Holdings, Inc. The usual dosage information is available, and the tablets should be stored at a temperature range of 20-25°C (68-77°F). The NDC number for the product is 16571-242-01, and it is available in a bottle containing 100 tablets. It also reminds to keep the medication out of the reach of children.*

FDA Label Image

Diclorophenamide-table 1.jpg (Diclorophenamide Table 1)

This document presents a list of adverse reactions associated with the medication Dichlorphenamide. The reactions are categorized by different body systems and include symptoms such as paresthesia, cognitive disorder, dysgeusia, diarrhea, nausea, fatigue, weight decrease, muscle spasms, arthralgia, dyspnea, pharyngolaryngeal pain, rash, and pruritus. This information can be used for evaluating and monitoring potential side effects of Dichlorphenamide treatment.*

FDA Label Image

Diclorophenamide-label.jpg (Diclorophenamide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.